Search - tctmd.com

Displaying 561 - 580 of 627

Sort: Relevancy | Date

News Conference News ESC 2012

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Caitlin E. Cox

August 28, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

News Conference News ESC 2012

STEMI Patient Population Evolves Over 15 Years

Yael L. Maxwell

August 27, 2012

Presentation ESC 2012

Rivaroxaban in Patients following a ST-Elevation Myocardial Infarction

Presenter: Jessica L. Mega

August 27, 2012

News Conference News ESC 2012

Registries Show Strides for Transcatheter Valve Treatments in Europe

Caitlin E. Cox

August 27, 2012

Presentation ESC 2012

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

Presenter: 168042|Holger Thiele

August 27, 2012

News Conference News ESC 2012

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

Yael L. Maxwell

August 27, 2012

Presentation ESC 2012

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Presenter: William Wijns

August 27, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

News Conference News ESC 2012

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

August 27, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

Presentation ESC 2012

ACCESS-EUROPE Phase I - A Post Market Study of the MitraClip System for the Treatment of Significant Mitral Regurgitation in Europe: Analysis of Outcomes at 1 Year

Presenter: Wolfgang Schillinger

August 27, 2012

Presentation ESC 2012

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Presenter: 205474|Benjamin Scirica

August 26, 2012

News Conference News ESC 2012

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Jason Kahn

August 26, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

Predictors of Aortic Regurgitation After TAVR Delineated

August 26, 2012

Presentation ESC 2012

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Presenter: 159942|Jolanta Siller-Matula

August 26, 2012

News Conference News ESC 2012

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

August 26, 2012

News Conference News ESC 2012

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Caitlin E. Cox

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

Advertisement

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

STEMI Patient Population Evolves Over 15 Years

Rivaroxaban in Patients following a ST-Elevation Myocardial Infarction

Registries Show Strides for Transcatheter Valve Treatments in Europe

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

ACCESS-EUROPE Phase I - A Post Market Study of the MitraClip System for the Treatment of Significant Mitral Regurgitation in Europe: Analysis of Outcomes at 1 Year

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Predictors of Aortic Regurgitation After TAVR Delineated

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content